Skip to main content
NeuroPace Inc logo

NeuroPace Inc — Investor Relations & Filings

Ticker · NPCE ISIN · US6412881053 US Manufacturing
Filings indexed 314 across all filing types
Latest filing 2026-04-21 Proxy Solicitation & In…
Country US United States of America
Listing US NPCE

About NeuroPace Inc

https://www.neuropace.com/

NeuroPace Inc. is a commercial-stage medical device company focused on the treatment of neurological disorders. The company designs, develops, and markets implantable devices that utilize responsive neurostimulation. Its flagship product, the RNS® System, is the only FDA-approved brain-responsive neurostimulation system for adults with drug-resistant focal epilepsy. The RNS System continuously monitors brain activity, detects patient-specific abnormal electrical patterns, and delivers personalized electrical stimulation in real-time to prevent seizures at their source. In addition to providing therapeutic stimulation, the device also records and provides physicians with long-term electroencephalographic (EEG) data to help optimize patient care and treatment plans.

Recent filings

Filing Released Lang Actions
DEF 14A - NeuroPace Inc (0001528287) (Filer)
Proxy Solicitation & Information Statement
2026-04-21 English
4 - NeuroPace Inc (0001528287) (Issuer)
Director's Dealing
2026-03-24 English
4 - NeuroPace Inc (0001528287) (Issuer)
Director's Dealing
2026-03-24 English
4 - NEUROPACE INC (0001528287) (Filer)
Director's Dealing
2026-03-04 English
10-K - NEUROPACE INC (0001528287) (Filer)
Annual Report FY 2025
2026-03-03 English
8-K - NEUROPACE INC (0001528287) (Filer)
Regulatory Filings
2026-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.